Abstract:A series of fluorescent thiazole–pyrazoline derivatives was synthesized and their structures were characterized by 1 H NMR, 13 C NMR, and HRMS. Biological evaluation demonstrated that these compounds could effectively inhibit the growth of human non-small cell lung cancer (NSCLC) A549 cells in a dose- and time-dependent manner in vitro and inhibit tumor growth in vivo. The structure–activity relationship (SAR) of the compounds was analyzed. Further mechanism research revealed they could induce autophagy and cell cycle arrest while had no influence on cell necrosis. Compound 5e inhibited the activity of mTOR via FKBP12, which could be reversed by 3BDO, an mTOR activator and autophagy inhibitor. Compound 5e inhibited growth, promoted autophagy of A549 cells in vivo. Moreover, compound 5e showed good selectivity with no influence on normal vascular endothelial cell growth and the normal chick embryo chorioallantoic membrane (CAM) capillary formation. Therefore, our research provides potential lead compounds for the development of new anticancer drugs against human lung cancer.

Synthesis and discovery of autophagy inducers for A549 and H460 lung cancer cells, novel 1-(2'-hydroxy-3'-aroxypropyl)-3-aryl-1H-pyrazole-5-carbohydrazide derivatives.

Synthesis and discovery of pyrazole-5-carbohydrazide N-glycosides as inducer of autophagy in A549 lung cancer cells.

Synthesis of Novel Pyrazole Carboxamide Derivatives and Discovery of Modulators for Apoptosis or Autophagy in A549 Lung Cancer Cells

Discovery of 2'-hydroxychalcones as autophagy inducer in A549 lung cancer cells.

Synthesis of novel substituted pyrazole-5-carbohydrazide hydrazone derivatives and discovery of a potent apoptosis inducer in A549 lung cancer cells.

Discovery of New Fluorescent Thiazole–pyrazoline Derivatives As Autophagy Inducers by Inhibiting Mtor Activity in A549 Human Lung Cancer Cells

Synthesis of Novel Oxime-Containing Pyrazole Derivatives and Discovery of Regulators for Apoptosis and Autophagy in A549 Lung Cancer Cells

Synthesis and preliminary biological evaluation of novel pyrazolo[1,5-a]pyrazin-4(5H)-one derivatives as potential agents against A549 lung cancer cells.

Synthesis, structure characterization and preliminary biological evaluation of novel 5-alkyl-2-ferrocenyl-6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one derivatives

Discovery of a New Autophagy Inducer for A549 Lung Cancer Cells

5-Alkyl-2-ferrocenyl-6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one derivatives inhibit growth of lung cancer A549 cell by inducing apoptosis.

Biological Activities of Novel Pyrazolyl Hydroxamic Acid Derivatives Against Human Lung Cancer Cell Line A549.

Synthesis of 6-Cinnamoyl-2h-benzo[b][1,4]oxazin-3(4h)-ones and Their Effects on A549 Lung Cancer Cell Growth.

Synthesis of 5-benzyl-2-phenylpyrazolo[1,5-a]pyrazin-4,6(5H,7H)-dione derivatives and discovery of an apoptosis inducer for H322 lung cancer cells.

Design, synthesis, and preliminary biological evaluation of novel ethyl 1-(2'-hydroxy-3'-aroxypropyl)-3-aryl-1H-pyrazole-5-carboxylate.

Synthesis and Structure-Activity Relationships of Novel 1-Arylmethyl-3-aryl-1h-pyrazole-5-carbohydrazide Hydrazone Derivatives As Potential Agents Against A549 Lung Cancer Cells

Synthesis of Pyrazole Peptidomimetics and Their Inhibition Against A549 Lung Cancer Cells

Novel 2-Amino-1,4-Naphthoquinone Derivatives Induce A549 Cell Death through Autophagy

Novel Indolyl-Chalcone Derivatives Inhibit A549 Lung Cancer Cell Growth Through Activating Nrf-2/Ho-1 and Inducing Apoptosis in Vitro and in Vivo

Synthesis and biological assessment of indole derivatives containing penta-heterocycles scaffold as novel anticancer agents towards A549 and K562 cells